Stephen Beard | Apr 9, 2007
Churches throughout England are facing uncertain financial futures, so they've been renting out space to earn some spare change. Some ecclesiastical authorities are not pleased. Stephen Beard reports.
Kai Ryssdal | Apr 9, 2007
The world's largest natural gas exporters are considering working more closely together to set prices. Vijay Vaitheeswaran, correspondent for The Economist, discusses potential impacts with Kai Ryssdal.
Sean Cole | Apr 9, 2007
Do you want an alarm clock that rings and runs? Sean Cole reports on the morning torture device called Clocky that can't be stopped.
Sean Cole | Apr 9, 2007
From beard taxes to yachts, history teaches that you never can tell how people will respond when you find a new way to tax them. Except that some of them will find some way to avoid paying it.
Hilary Wicai | Apr 9, 2007
Turns out our first president wasn't the teetotaler some revisionists have made him out to be. In fact, Washington was once the nation's largest producer of whiskey. And now a rebuilt version of his distillery is open to the public.
Stephen Beard and Scott Jagow | Apr 9, 2007
Rising energy costs and advances in technology have given new life to efforts to form an OPEC-like cartel for natural gas. It's probably a long way off, but if it happens, it won't be good for consumers.
John Dimsdale | Apr 9, 2007
President Bush is asking Congress for comprehensive immigration reform, but a sizable House caucus opposed to any form of amnesty wants to split up immigration issues and pass the less controversial measures.
Dan Grech | Apr 9, 2007
Workplace raids have succeeded in scaring off illegal immigrant workers — but that's left many farms and businesses struggling to maintain production levels and Congress struggling to agree on a solution.
Scott Tong | Apr 9, 2007
The U.S. is expected to file new complaints with the WTO this week saying China isn't doing enough to fight piracy and counterfeits. Beijing has made it easier to prosecute the crimes, but the problem is built into its restrictive market.
Helen Palmer | Apr 9, 2007
Prevnar is an expensive vaccine but effective in preventing deadly diseases such as meningitis, so doctors have been using it despite the high cost. Now evidence that it also cuts pneumonia cases makes its price tag seem even more reasonable.